| Pharmaceutical active ingredients: |
| Diloxanide FuroateMetronidazole |
| Available forms, composition and doses of Qugyl: |
| Tablets, Film-Coated; Oral; Diloxanide Furoate 250 mg; Metronidazole 200 mg |
| Qugyl medical category: |
| Human:AntiamoebicsAntiprotozoal agentsAntiamoebics, other antiprotozoal agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| P01AB01 - MetronidazoleP01AC01 - Diloxanide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| RPG Life Sciences |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Dyrade-M | Diloxanide Furoate; Metronidazole | Cipla |
| Dyrade-M DS | Diloxanide Furoate; Metronidazole | Cipla |
| Entamizole | Diloxanide Furoate; Metronidazole | Abbott; Waymade Healthcare |
| Metrogyl Compound | Diloxanide Furoate; Metronidazole | Unique Pharmaceutical Laboratories; J.B. Chemicals & Pharmaceuticals |
| Metron-DF | Diloxanide Furoate; Metronidazole | Alkem Laboratories |
| Qugyl-DS | Diloxanide Furoate; Metronidazole | RPG Life Sciences |
| Sprot | Diloxanide Furoate; Metronidazole | Mapra Laboratories |
| Aristogyl Plus | Diloxanide Furoate; Metronidazole; Simethicone | Aristo Pharmaceuticals |
| Sprot Plus | Diloxanide Furoate; Metronidazole; Simethicone | Mapra Laboratories |
| Tinilox MPS Suspension | Diloxanide Furoate; Simethicone; Tinidazole | Yash Vision |